These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 20379157)
1. Roche plans for more convenient-to-use Herceptin and Rituxan. Ratner M Nat Biotechnol; 2010 Apr; 28(4):298. PubMed ID: 20379157 [No Abstract] [Full Text] [Related]
2. HUMIRA pen: a novel autoinjection device for subcutaneous injection of the fully human monoclonal antibody adalimumab. Kivitz A; Segurado OG Expert Rev Med Devices; 2007 Mar; 4(2):109-16. PubMed ID: 17359217 [TBL] [Abstract][Full Text] [Related]
3. Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin (bevacizumab), Remicade (infliximab) and Herceptin (trastuzumab). Peters BJ; Capelle MA; Arvinte T; van de Garde EM MAbs; 2013; 5(1):162-70. PubMed ID: 23255057 [TBL] [Abstract][Full Text] [Related]
4. [Preparation of hematoporphyrin-herceptin photoimmunoconjugate for photoimmunotherapy]. Chen L; Luo RC; Li LB; Yan X; Ding XM Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):355-7. PubMed ID: 16546747 [TBL] [Abstract][Full Text] [Related]
5. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Hodoniczky J; Zheng YZ; James DC Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047 [TBL] [Abstract][Full Text] [Related]
7. Site transfer and process validation in case of Herceptin API. Kuhne W Dev Biol (Basel); 2003; 113():47-50. PubMed ID: 14620851 [TBL] [Abstract][Full Text] [Related]
8. Accuracy, precision and repeatability in preparing the intravitreal dose with a 1.0-cc syringe. Meyer CH; Liu Z; Brinkmann C; Rodrigues EB; Helb HM Acta Ophthalmol; 2012 Mar; 90(2):e165-6. PubMed ID: 21470379 [No Abstract] [Full Text] [Related]
9. [Insulin pen needles can be re-used safely]. Berger B Lakartidningen; 2004 Dec; 101(49):4046, 4049. PubMed ID: 15633349 [No Abstract] [Full Text] [Related]
10. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development. Yan L; Beckman RA Biotechniques; 2005 Oct; 39(4):565-8. PubMed ID: 16235569 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of a insulin syringe with a security system]. Clergé MJ; Marre M Soins; 2003 Jun; (676):20-1. PubMed ID: 12852267 [No Abstract] [Full Text] [Related]
14. [These modern syringes are rubbish]. Urch T MMW Fortschr Med; 2014 Nov; 156(19):8. PubMed ID: 25509994 [No Abstract] [Full Text] [Related]
15. Subcutaneous administration of monoclonal antibodies: a small space to inject, a big challenge to conquer. Shameem M Ther Deliv; 2016; 7(1):5-6. PubMed ID: 26652618 [No Abstract] [Full Text] [Related]
16. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use. Schwartz SL; Ignaut DA; Bodie JN Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084 [TBL] [Abstract][Full Text] [Related]
17. Recurrent diabetic ketoacidosis after changing pen devices for insulin injection. Bhardwaj VR; Metcalfe N; Innes E; Harrison E; Jenkins D BMJ; 2006 May; 332(7552):1259-60. PubMed ID: 16735337 [No Abstract] [Full Text] [Related]
18. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Lee AL; Wang Y; Cheng HY; Pervaiz S; Yang YY Biomaterials; 2009 Feb; 30(5):919-27. PubMed ID: 19042015 [TBL] [Abstract][Full Text] [Related]
19. The compatibility and stability of midazolam and dexamethasone in infusion solutions. Good PD; Schneider JJ; Ravenscroft PJ J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775 [TBL] [Abstract][Full Text] [Related]
20. Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies. Larson AM; Weight AK; Love K; Bonificio A; Wescott CR; Klibanov AM J Pharm Sci; 2017 May; 106(5):1211-1217. PubMed ID: 28137697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]